XERS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own XERS shares is 187, representing 44.07% of the company's common stock.

AMERICAN INTERNATIONAL GROUP, INC., in the last quarter, reduced its stake in XERS by -0.85% restricting it's holding to 65.58 thousand shares of worth nearly $144.93K. STRS OHIO also lessened -5.91% of the XERS shares from its portfolio, reducing its holding to 60.5 thousand shares of worth $133.00K. METLIFE INVESTMENT MANAGEMENT, LLC also shunned XERS shares holding by -18.45% last quarter which brought its holding to 58.09 thousand shares worth $128.38K.

As per its latest 13F filing, PRINCIPAL FINANCIAL GROUP INC increased its stake in XERS by 100.38% in the last quarter. The institutional holder raised its holding to 89.62 thousand shares having worth more than $198.06K. SIGMA PLANNING CORP also added 100% more shares of XERS to its portfolio, raising its holding to 76.55 thousand shares of worth $169.18K. DYNAMIC TECHNOLOGY LAB PRIVATE LTD also increased its XERS shares holding by 100% which brought its holding to 68.85 thousand shares worth $153.00K.

The insider with the most stakes in XERS is Redmile Group, LLC , 10 percent owner at the company. Additionally, XERS stock is highly held by See Remarks Edick Paul R and 10 percent owner Palmetto Partners, Ltd. among others.

Company executives, directors, and other insiders own 3.92% percent of Xeris Biopharma Holdings, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which XERS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PRESTRELSKI STEVEN and FLYNN JAMES E.

There have been 2 transaction(s) during the past 6-months in which Xeris Biopharma Holdings, Inc. insiders have bought stock, totalling 8800 shares

Around 45.89K Xeris Biopharma Holdings, Inc. shares are held by insiders, which represents about 3.92% of XERS stock.

XERS 10 percent owner, Redmile Group, LLC holds the largest portfolio of the company's shares. XERS shares owned by Redmile total nearly 3 million.

PRINCIPAL FINANCIAL GROUP INC is the largest institutional owner in XERS which holds 89.62 thousand shares worth $198.06K or 0.06% of the total XERS shares outstanding followed by ALLIANCEBERNSTEIN L.P. with ownership of 80.42 thousand shares representing 0.06% of the XERS ownership. SIGMA PLANNING CORP is the third largest stakeholder with 76.55 thousand shares or 0.06% of the ownership worth more than $169.18K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the XERS is concerned, it is a stock which is optionable.

Number of XERS shares short is 10.36M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 149.08M shares of XERS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, XERS has 142.50M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for XERS is 7.37.